BR112012006519A2 - síntese de t-butil éster de ácido (4-fluór-3-piperidin-4-il-benzin)-carbâmico e seus intermediários - Google Patents

síntese de t-butil éster de ácido (4-fluór-3-piperidin-4-il-benzin)-carbâmico e seus intermediários

Info

Publication number
BR112012006519A2
BR112012006519A2 BR112012006519A BR112012006519A BR112012006519A2 BR 112012006519 A2 BR112012006519 A2 BR 112012006519A2 BR 112012006519 A BR112012006519 A BR 112012006519A BR 112012006519 A BR112012006519 A BR 112012006519A BR 112012006519 A2 BR112012006519 A2 BR 112012006519A2
Authority
BR
Brazil
Prior art keywords
compound
fluoro
butyl
carbamic acid
piperidin
Prior art date
Application number
BR112012006519A
Other languages
English (en)
Inventor
Adam W Sledeski
John J Shay Jr
Nakyen Choy
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of BR112012006519A2 publication Critical patent/BR112012006519A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44Palladium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

síntese de t-butil éster de ácido (4-flúor-3-piperidin-4-il-benzil)-carbâmico e seus intermediários. a presente invenção refere-se a um método melhorado para a preparação de t-butil éster de ácido (4-flúor-3-piperidin-4-il-benzil)-carbâmico, composto de fórmula i. a invenção refere-se a um método de síntese para o composto de fórmula i em três etapas, compreendendo a formação de ácido 5-((t-butoxicarbonil)aminometil)-2-fluorobenzenoborônico (composto 11), reação de composto 11 sob condições de acoplamento suzuki para formar t-butil estér de ácido (4-flúor-2-piridin-4-il-benzil)-carbâmico e hidrogenação seletiva do produto acima mencionado em condições de hidrogenação, fornecendo o composto i. a invenção também se refere aos intermediários ácido 5-((t-butoxicarbonil)amino-metil)-2-fluorobenzeno borônico (composto 11), e t-butil éster de ácido (4-flúor-2-piridin-3-il-benzil)-carbâmico- (composto 13).
BR112012006519A 2009-09-24 2010-09-22 síntese de t-butil éster de ácido (4-fluór-3-piperidin-4-il-benzin)-carbâmico e seus intermediários BR112012006519A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24532509P 2009-09-24 2009-09-24
PCT/US2010/049737 WO2011037947A1 (en) 2009-09-24 2010-09-22 Synthesis of (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester and intermediates thereof

Publications (1)

Publication Number Publication Date
BR112012006519A2 true BR112012006519A2 (pt) 2015-09-08

Family

ID=42984934

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012006519A BR112012006519A2 (pt) 2009-09-24 2010-09-22 síntese de t-butil éster de ácido (4-fluór-3-piperidin-4-il-benzin)-carbâmico e seus intermediários

Country Status (14)

Country Link
US (1) US8633321B2 (pt)
EP (1) EP2483243B1 (pt)
JP (1) JP2013505935A (pt)
KR (1) KR20120083357A (pt)
CN (1) CN102574792B (pt)
AU (1) AU2010298425A1 (pt)
BR (1) BR112012006519A2 (pt)
CA (1) CA2774614C (pt)
IL (1) IL218680A0 (pt)
MX (1) MX2012003023A (pt)
MY (1) MY155682A (pt)
RU (1) RU2543483C2 (pt)
SG (1) SG179201A1 (pt)
WO (1) WO2011037947A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011037947A1 (en) 2009-09-24 2011-03-31 Sanofi-Aventis U.S. Llc Synthesis of (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester and intermediates thereof
CA2812718C (en) * 2010-09-27 2018-11-27 E. I. Du Pont De Nemours And Company Method for preparing 2-amino-n-(2,2,2-trifluoroethyl)acetamide
JP6578116B2 (ja) * 2015-03-25 2019-09-18 公益財団法人相模中央化学研究所 一置換(フルオロアルキル)エチレン類及びその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912339D0 (en) * 1989-05-30 1989-07-12 Merck Patent Gmbh Fluorinated biphenyl derivatives
US6248103B1 (en) 1994-04-05 2001-06-19 The Regents Of The University Of California Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery using long laser pulses
DE10101022A1 (de) * 2001-01-11 2002-07-18 Clariant Internat Ltd Muttenz Fluorierte Aromaten und ihre Verwendung in Flüssigkristallmischungen
JP2005111003A (ja) * 2003-10-08 2005-04-28 Kita Denshi Corp 遊技場システム、現金管理装置及び搬送異常検出方法
EP1571150A1 (en) * 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Process for the preparation of tryptase inhibitors
DOP2005000039A (es) * 2004-03-26 2005-10-31 Aventis Pharma Inc Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
MXPA06012595A (es) * 2004-04-29 2007-05-09 Abbott Lab Analogos de amino-tetrazoles y metodos de uso.
WO2011037947A1 (en) 2009-09-24 2011-03-31 Sanofi-Aventis U.S. Llc Synthesis of (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester and intermediates thereof

Also Published As

Publication number Publication date
EP2483243B1 (en) 2015-03-18
SG179201A1 (en) 2012-05-30
MX2012003023A (es) 2012-04-10
CN102574792B (zh) 2014-07-09
US20120184745A1 (en) 2012-07-19
RU2012116346A (ru) 2013-10-27
IL218680A0 (en) 2012-05-31
CA2774614C (en) 2015-03-10
AU2010298425A1 (en) 2012-04-19
WO2011037947A1 (en) 2011-03-31
KR20120083357A (ko) 2012-07-25
RU2543483C2 (ru) 2015-03-10
EP2483243A1 (en) 2012-08-08
JP2013505935A (ja) 2013-02-21
CN102574792A (zh) 2012-07-11
US8633321B2 (en) 2014-01-21
CA2774614A1 (en) 2011-03-31
MY155682A (en) 2015-11-13

Similar Documents

Publication Publication Date Title
IN2012DN02751A (pt)
WO2011015522A3 (en) Process for the manufacture of pharmaceutically active compounds
BR112013001245A2 (pt) método de produção de ingenol-3-angelato
GEP20125512B (en) Process for synthesis of agomelatin
UA102817C2 (ru) Способ синтеза агомелатина
WO2009095933A3 (en) Improved and novel process for the preparation of bosentan
BRPI0710199A2 (pt) Processo para preparação de inibidores de hiv protease
AR117002A2 (es) Proceso para la preparación de inhibidores de quinasa c-fms
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
HK1168102A1 (en) Process for the preparation of a compound useful as an inhibitor of tafia
EA201390336A1 (ru) Способ получения промежуточного соединения для синтеза лекарственного средства
BR112012006519A2 (pt) síntese de t-butil éster de ácido (4-fluór-3-piperidin-4-il-benzin)-carbâmico e seus intermediários
EA200900008A1 (ru) Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
GEP20115344B (en) New process for synthesis of agomelatine
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
AR060622A1 (es) Proceso para la preparcion del ester 2-[ 4-(4- fluoro-2 - metil-1h -indol-5- iloxi)-5-metil pirrolo [2,1-f] [ 1,2,4] triazin -6-iloxi] -1- metiletilico del acido [(1r),2s ] -2- aminopropinoico
WO2012113999A8 (fr) Procede et intermediaires de synthese de l ' agomelatine
WO2011022429A3 (en) Process for the preparation of (s)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof
MD20130092A2 (ro) Procedeu nou de sinteză a 3-(2-bromo-4,5-dimetoxifenil)propannitril şi aplicarea în sinteza ivabradinei şi a sărurilor sale de adiţie cu un acid farmaceutic acceptabil
NZ598129A (en) Process for the preparation of cathepsin s inhibitors
ATE542822T1 (de) Stereoselektive synthese bestimmter trifluormethyl-substituierter alkohole
MX2013002656A (es) Nuevo proceso.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.